STAT

BIO in 30 Seconds

Dispatches from the BIO International Convention in San Diego.

We are on the ground in San Diego! Follow us on Twitter for more updates: @damiangarde@rebeccadrobbins@megkesh, and of course, @statnews

Making up for past snubs

Massachusetts Gov.(which is basically an extension of his predecessor’s 10-year, $1 billion program to promote life sciences). He’ll also be trying to get a sense of how these BIO bashes work: Boston is slated to host next year’s confab.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks